GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

Ascendis Pharma A/S Company Profile

Tuborg Boulevard 5

Hellerup 2900

45 36 94 44 86

www.ascendispharma.com

Industry: Biotechnology

Sector: Healthcare

Ascendis Pharma A/S

Description

Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies to treat unmet medical needs. It is developing TransCon human growth hormone that has completed Phase II clinical trials in children and adults to treat growth hormone deficiency (GHD) and other indications; and TransCon Treprostinil that has completed Phase I clinical trial for the treatment of pulmonary arterial hypertension, a life-threatening disease characterized by elevated blood pressure in the pulmonary arteries. The company is also developing TransCon Peptides for the treatment of diabetes; and TransCon Ranibizumab, a compound to support injection of ranibizumab. It has strategic collaborations with Sanofi and Genentech. Ascendis Pharma A/S was founded in 2006 and is headquartered in Hellerup, Denmark.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE